02-20917. Agency Information Collection Activities; Submission for OMB Review; Comment Request; Veterinary Feed Directive
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that the proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).
DATES:
Submit written comments on the collection of information by September 18, 2002.
Start Printed Page 53807ADDRESSES:
Submit written comments on the collection of information to the Office of Information and Regulatory Affairs, OMB, New Executive Office Bldg., 725 17th St. NW., rm 10235, Washington, DC 20503, Attn: Stuart Shapiro, Desk Officer for FDA.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Denver Presley, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1472.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Veterinary Feed Directive—21 CFR Part 558 (OMB Control Number 0910-0363)—Extension
The veterinary feed directive (VFD) drugs section of the Animal Drug Availability Act of 1996 (ADAA) (Public Law 104-250) established a new class of restricted feed use drugs that may be distributed without invoking State pharmacy laws. In order to implement the VFD drugs section of the ADAA, FDA issued regulations (65 FR 76924, December 8, 2000) that impose reporting and recordkeeping requirements on veterinarians, distributors of animal feeds containing VFD drugs, and clients using medicated feeds containing VFD drugs. All distributors of animal feed containing VFD drugs must notify FDA of their intent to distribute animal feed containing a VFD drug, and must maintain records of the distribution of all animal feeds containing VFD drugs (21 CFR 558.6).
In the Federal Register of April 30, 2002 (67 FR 21252), the agency requested comments on the proposed collection of information. FDA received one comment.
The comment asked if the proposed collection of information was necessary for the proper performance of FDA functions and whether the information will have practical utility. The answer is yes. As detailed, the VFD regulation ensures protection of public health while enabling animal producers to obtain and use needed drugs as efficiently and cost-effectively as possible.
Respondents to this collection of information are veterinarians, distributors of animal feeds containing VFD drugs, and clients using medicated feeds containing VFD drugs.
FDA estimates the burden for this collection of information as follows:
Table 1.—Estimated Annual Reporting Burden1
21 CFR Section No. of Respondents Annual Frequency per Response Total Annual Responses Hours per Response Total Hours 558.6(a)(3) through (a)(5) 15,000 25 375,000 0.25 93,750 558.6(d)(1)(i) through (d)(1)(iii) 1,500 1 500 0.25 125 558.6(d)(1)(iv) 20 1 20 0.25 5 558.6(d)(2) 1,000 5 5,000 0.25 1,250 514.1(b)(9) 1 1 1 3.00 3 Total 95,133 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Table 2.—Estimated Annual Recordkeeping Burden1
21 CFR Section No. of Recordkeepers Annual Frequency per Recordkeeper Total Annual Records Hours per Record Total Hours 558.6(c)(1) through (c)(4) 112,500 10 1,125,000 .0167 18,788 558.6(e)(1) through (e)(3) 5,000 75 375,000 .0167 6,263 Total 25,051 1 There are no capital costs or operating and maintenance costs associated with this collection of information. These estimates are based on agency communication with industry. Other information needed to calculate the total burden hours are derived from agency records and experience.
Start SignatureDated: August 13, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-20917 Filed 8-16-02; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Published:
- 08/19/2002
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 02-20917
- Dates:
- Submit written comments on the collection of information by September 18, 2002.
- Pages:
- 53806-53807 (2 pages)
- Docket Numbers:
- Docket No. 02N-0116
- PDF File:
- 02-20917.pdf